226 related articles for article (PubMed ID: 34670511)
1. Clinical verification of body mass index and tumor immune response in patients with breast cancer receiving preoperative chemotherapy.
Takada K; Kashiwagi S; Asano Y; Goto W; Ishihara S; Morisaki T; Shibutani M; Tanaka H; Hirakawa K; Ohira M
BMC Cancer; 2021 Oct; 21(1):1129. PubMed ID: 34670511
[TBL] [Abstract][Full Text] [Related]
2. Verification of the effects of calcium channel blockers on the immune microenvironment of breast cancer.
Takada K; Kashiwagi S; Asano Y; Goto W; Takahashi K; Fujita H; Takashima T; Tomita S; Hirakawa K; Ohira M
BMC Cancer; 2019 Jun; 19(1):615. PubMed ID: 31234828
[TBL] [Abstract][Full Text] [Related]
3. Obesity is an independent prognostic factor of decreased pathological complete response to neoadjuvant chemotherapy in breast cancer patients.
Karatas F; Erdem GU; Sahin S; Aytekin A; Yuce D; Sever AR; Babacan T; Ates O; Ozisik Y; Altundag K
Breast; 2017 Apr; 32():237-244. PubMed ID: 27318645
[TBL] [Abstract][Full Text] [Related]
4. Impact of Serum Albumin Levels and Body Mass Index on Outcomes of Open Abdominal Aortic Aneurysm Repair in Korean Population.
Park JK; Park YJ; Yang SS; Kim DI; Kim YW
Ann Vasc Surg; 2024 Apr; 101():139-147. PubMed ID: 38211897
[TBL] [Abstract][Full Text] [Related]
5. Differences in tumor-infiltrating lymphocyte density and prognostic factors for breast cancer by patient age.
Takada K; Kashiwagi S; Asano Y; Goto W; Morisaki T; Shibutani M; Tanaka H; Hirakawa K; Ohira M
World J Surg Oncol; 2022 Feb; 20(1):38. PubMed ID: 35177074
[TBL] [Abstract][Full Text] [Related]
6. Short-term and long-term outcomes of oesophagogastric surgery for cancer in obese and normal weight patients.
Glatz T; Kulemann B; Kuvendjiska J; Fichtner-Feigl S; Hoeppner J
ANZ J Surg; 2020 Mar; 90(3):277-282. PubMed ID: 31854089
[TBL] [Abstract][Full Text] [Related]
7. Body Mass Index as a Prognostic Factor in Resected Lung Cancer: Obesity or Underweight, Which Is the Risk Factor?
Matsunaga T; Suzuki K; Imashimizu K; Banno T; Takamochi K; Oh S
Thorac Cardiovasc Surg; 2015 Oct; 63(7):551-7. PubMed ID: 26277079
[TBL] [Abstract][Full Text] [Related]
8. Tumor-Infiltrating Lymphocytes in Low-Risk Patients With Breast Cancer Treated With Single-Dose Preoperative Partial Breast Irradiation.
Vasmel JE; Vreuls CPH; Manson QF; Charaghvandi RK; van Gorp J; van Leeuwen AMG; van Diest PJ; Verkooijen HM; van den Bongard HJGD
Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1325-1331. PubMed ID: 33333201
[TBL] [Abstract][Full Text] [Related]
9. Use of Tumor-infiltrating lymphocytes (TILs) to predict the treatment response to eribulin chemotherapy in breast cancer.
Kashiwagi S; Asano Y; Goto W; Takada K; Takahashi K; Noda S; Takashima T; Onoda N; Tomita S; Ohsawa M; Hirakawa K; Ohira M
PLoS One; 2017; 12(2):e0170634. PubMed ID: 28166544
[TBL] [Abstract][Full Text] [Related]
10. Study on the progression types of cancer in patients with breast cancer undergoing eribulin chemotherapy and tumor microenvironment.
Kashiwagi S; Tsujio G; Asano Y; Goto W; Takada K; Takahashi K; Morisaki T; Fujita H; Takashima T; Tomita S; Ohsawa M; Hirakawa K; Ohira M
J Transl Med; 2018 Mar; 16(1):54. PubMed ID: 29523158
[TBL] [Abstract][Full Text] [Related]
11. Associations between absolute neutrophil count and lymphocyte-predominant breast cancer.
Yoon CI; Park S; Cha YJ; Lee HS; Bae SJ; Cha C; Lee DY; Ahn SG; Jeong J
Breast; 2020 Apr; 50():141-148. PubMed ID: 31607527
[TBL] [Abstract][Full Text] [Related]
12. Effect of body mass index on surgical outcomes after posterior spinal fusion for adolescent idiopathic scoliosis.
De la Garza Ramos R; Nakhla J; Nasser R; Schulz JF; Purvis TE; Sciubba DM; Kinon MD; Yassari R
Neurosurg Focus; 2017 Oct; 43(4):E5. PubMed ID: 28965443
[TBL] [Abstract][Full Text] [Related]
13. Clinical verification of the relationship between smoking and the immune microenvironment of breast cancer.
Takada K; Kashiwagi S; Asano Y; Goto W; Takahashi K; Fujita H; Takashima T; Tomita S; Hirakawa K; Ohira M
J Transl Med; 2019 Jan; 17(1):13. PubMed ID: 30616624
[TBL] [Abstract][Full Text] [Related]
14. Interaction between Molecular Subtypes and Stromal Immune Infiltration before and after Treatment in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy.
Hamy AS; Bonsang-Kitzis H; De Croze D; Laas E; Darrigues L; Topciu L; Menet E; Vincent-Salomon A; Lerebours F; Pierga JY; Brain E; Feron JG; Benchimol G; Lam GT; Laé M; Reyal F
Clin Cancer Res; 2019 Nov; 25(22):6731-6741. PubMed ID: 31515462
[TBL] [Abstract][Full Text] [Related]
15. Prediction of Treatment Response to Neoadjuvant Chemotherapy in Breast Cancer by Subtype Using Tumor-infiltrating Lymphocytes.
Asano Y; Kashiwagi S; Goto W; Takada K; Takahashi K; Hatano T; Takashima T; Tomita S; Motomura H; Ohsawa M; Hirakawa K; Ohira M
Anticancer Res; 2018 Apr; 38(4):2311-2321. PubMed ID: 29599354
[TBL] [Abstract][Full Text] [Related]
16. The number of FoxP3-positive tumor-infiltrating lymphocytes in patients with synchronous bilateral breast cancer.
Goto R; Hirota Y; Aruga T; Horiguchi S; Miura S; Nakamura S; Takimoto M
Breast Cancer; 2020 Jul; 27(4):586-593. PubMed ID: 31933123
[TBL] [Abstract][Full Text] [Related]
17. Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy.
Denkert C; von Minckwitz G; Darb-Esfahani S; Lederer B; Heppner BI; Weber KE; Budczies J; Huober J; Klauschen F; Furlanetto J; Schmitt WD; Blohmer JU; Karn T; Pfitzner BM; Kümmel S; Engels K; Schneeweiss A; Hartmann A; Noske A; Fasching PA; Jackisch C; van Mackelenbergh M; Sinn P; Schem C; Hanusch C; Untch M; Loibl S
Lancet Oncol; 2018 Jan; 19(1):40-50. PubMed ID: 29233559
[TBL] [Abstract][Full Text] [Related]
18. Morphological Evaluation of Tumor-Infiltrating Lymphocytes (TILs) to Investigate Invasive Breast Cancer Immunogenicity, Reveal Lymphocytic Networks and Help Relapse Prediction: A Retrospective Study.
Romagnoli G; Wiedermann M; Hübner F; Wenners A; Mathiak M; Röcken C; Maass N; Klapper W; Alkatout I
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28885584
[TBL] [Abstract][Full Text] [Related]
19. Impact of body mass index on pathological complete response and survival of breast cancer patients receiving neoadjuvant chemotherapy.
Aguiar D; Ros L; Pérez D; Croissier L; Mori M; Hernández M; Vargas AM; Galván S; Antonilli C; Saura S
Breast Dis; 2022; 41(1):351-361. PubMed ID: 36031886
[TBL] [Abstract][Full Text] [Related]
20. Prediction of lymph node metastasis by tumor-infiltrating lymphocytes in T1 breast cancer.
Takada K; Kashiwagi S; Asano Y; Goto W; Kouhashi R; Yabumoto A; Morisaki T; Shibutani M; Takashima T; Fujita H; Hirakawa K; Ohira M
BMC Cancer; 2020 Jun; 20(1):598. PubMed ID: 32590956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
